Requirements of an effective adherence-persistence program using the example of oral diabetics for diabetes mellitus type 2 patients;Anforderungen an ein effektives Adherence-Persistence-Programm am Beispiel von oralen Antidiabetika bei Diabetes mellitus Typ 2-Patienten

Gesundheitsokonomie und Qualitatsmanagement

Volumn 16, Issue 5, 2011, Pages 274-291

  Wilke, T ^a   Muller S ^a   Groth, A ^a   Maywald, U ^b   Verheyen, F ^c  

^a Hochschule Wismar   (Germany)

^b AOK Plus ^*  (Germany)

^c WINEG Wissenschaftliches   (Germany)

Author keywords

adherence programs interventions; diabetes; nonadherence; noncompliance; nonpersistence

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ARTICLE; EMBASE; GERMANY; GLUCOSE BLOOD LEVEL; HEALTH CARE SYSTEM; HUMAN; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; SYSTEMATIC REVIEW; TREATMENT REFUSAL;

EID: 80055032059     PISSN: 14322625     EISSN: 14394049     Source Type: Journal    
DOI: 10.1055/s-0031-1273282     Document Type: Article

References (100)

1. Grossmann M. On the Concept of Health Capital and the Demand for Health. Journal of Political Economy 1972 80 (2) 223-255
2. Folland S, Goodman A, Stano M. The Economics of health and Health Care. 3. Aufl. New Jersey Prentice-Hall, Upper Saddle River
3. World Health Organization. Adherence to long-term therapies. WHO Library Cataloguing-in-Publication Data 2003
4. Horne R, Weinman J, Barber N et al. Concordance, adherence and compliance in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D 2005
5. Cramer J A., Roy A, Burrell A et al. Medication compliance and persistence: terminology and definitions. Value Health 2008 11 (1) 44-47 (Pubitemid 351160875)
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 353 487-497 (Pubitemid 41127293)
7. National Council on Patient Information and Education. Enhancing Prescription Medicine Adherence: A National Action Plan. The NCPIE Coalition 2007
8. Krueger K P., Berger B A., Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther 2005 22 (4) 313-356 (Pubitemid 43003324)
9. Wilke T, Moock J, Müller S et al. Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopedic surgery. Clinical Orthopedics and Related Research 2010 468 (9) 2437-2453
10. Haynes R B., Ackloo E, Sahota N et al. Interventions for enhancing medication adherence. The Cochrane Database of Systematic Reviews 2008
11. Cleemput I, Kesteloot K, DeGeest S. A review of the literature on the economics of noncompliance. Health Policy 2001 59 (1) 65-94
12. Salas M, Hughes D, Zuluaga A et al. Cost of Medication Nonadherence in Patients with Diabetes Mellitus. Value Health 2009 12 (6) 915-922
13. White T J., Vanderplas A, Chang E et al. The cost of nonadherence to oral antihyperglycemic medication in individuals with diabetes mellitus and concomitant diabetes mellitus and cardiovascular disease in a managed care environment. Dis Manage Health Outcomes 2004 12 (3) 181-188 (Pubitemid 38845095)
14. Gorenoi V, Schönermark M P., Hagen A. HTA-Bericht: Maßnahmen zur Verbesserung der Adherence in der Arzneimitteltherapie. Deutsches Institut für Medizinische Dokumentation und Information 2007
15. Berg J S., Dischler J, Wagner D J. et al. Medication compliance: a healthcare problem. Ann Pharmacother 1993 27 (9 Suppl) 1-24
16. Rothenbacher D, Rüter G, Saam S et al. Management of patients with type 2 diabetes. Results in 12 practices of general practitioners. Dtsch Med Wochenschr 2002 127 (22) 1183-1187 (Pubitemid 34625911)
17. Turner R C., Cull C A., Frighi V, UK Prospective Diabetes Study Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999 281 (21) 2005-2012 (Pubitemid 29254858)
18. DeFronzo R A. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 2000 133 (1) 73-74 (Pubitemid 30432548)
19. Stephens J M., Botteman M F., Hay J W. Economic impact of antidiabetic medications and glycemic control on managed care organizations: a review of the literature. J Manag Care Pharm 2006 12 (2) 130-142 (Pubitemid 47400606)
20. Wagner E H., Sandhu N, Newton K M. et al. Effect of improved glycemic control on health care costs and utilization. JAMA 2001 285 (2) 182-189 (Pubitemid 32048520)
21. Matthaei S, Bierwirth R, Fritsche A et al. Medikamentöse antihyperglykämische Therapie der Diabetes mellitus Typ 2. Update der Evidenzbasierten Leitlinie der Deutschen Diabetes-Gesellschaft. Diabetologie 2009 4 32-64
22. Hader C, Beischer W, Braun A et al. Evidenzbasierte Leitlinie: Diabetes mellitus im Alter. Geriatrie Journal 2004 4 13-18
23. Rubin R R., Peyrot M, Siminerio L M. Health care and patient-reported outcomes: results of the cross-national Diabetes attitudes, wishes and needs (DAWN) study. Diabetes Care 2006 29 (6) 1249-1255 (Pubitemid 44125918)
24. Renders C M., Valk G D., Griffin S J. et al. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database of Systematic Reviews 2009
25. Kiblinger L, Braza N L. The impact of diabetes education on improving patient outcomes. Insulin 2007 2 (1) 24-30 (Pubitemid 47324324)
26. Littenberg B, MacLean C D., Hurowitz L. The use of adherence aids by adults with diabetes: a cross-sectional survey. BMC Fam Pract 2006 7 1
27. Rosen M I., Rigsby M O., Salahi J T. et al. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther 2004 42 409-422 (Pubitemid 38283822)
28. Kardas P. The DIACOM study (effect of dosing frequency of oral antidiabetic agents on the compliance and biochemical control of type 2 diabetes. Diabetes Obes Metab 2005 7 (6) 722-728 (Pubitemid 41601077)
29. Thiebaud P, Demand M, Wolf S A. et al. Impact of disease mangement on utilization and adherence with drugs and tests: the case of diabetes treatment in the Florida: a Healthy State (FAHS) program. Diabetes Care 2008 31 (9) 1717-1722
30. Piette J D., Weinberger M, McPhee S J. et al. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med 2000 108 (1) 20-27 (Pubitemid 30058274)
31. Charpentier G, Fleury F, Dubroca I et al. Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes Metab 2005 31 (2) 189-195 (Pubitemid 40577203)
32. Skaer T L., Sclar D A., Markowski D J. et al. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther 1993 18 (4) 295-299 (Pubitemid 23235099)
33. Grant R W., Devita N G., Singer D E. et al. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother 2003 37 (7 8) 962-969 (Pubitemid 36875222)
34. Odegard P S., Goo A, Hummel J et al. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother 2005 39 (3) 433-440 (Pubitemid 40270910)
35. Vimalavathini R, Agarwal S M., Gitanjali B. Educational program for patients with type-1 diabetes mellitus receiving free monthly supplies of insulin improves knowledge and attitude, but not adherence. Int J Diabetes Dev Ctries 2008 28 (3) 86-90
36. Albisser A M., Harris R I., Albisser J B. et al. The impact of initiatives in education, self-management training, and computer-assisted self-care on outcomes in diabetes disease management. Diabetes Technol Ther 2001 3 (4) 571-579 (Pubitemid 34202915)
37. Cho J H., Lee H C., Lim D J. et al. Mobile communication using a mobile phone with a glucometer for glucose control in type 2 patients with diabetes: as effective as an internet-based glucose monitoring system. J Telemed Telecare 2009 15 (2) 77-82
38. Simmons D, Upjohn M, Gamble G D. Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Diabetes Care 2000 23 (2) 153-156 (Pubitemid 30071016)
39. Kirwin J L., Cunningham R J., Sequist T D. Pharmacist Recommendations to Improve the Quality of Diabetes Care: A Randomized Controlled Trial. J Manag Care Pharm 2010 16 (2) 104-113
40. Matsuyama J R., Mason B J., Jue S G. Pharmacists interventions using an electronic medication-event monitoring devices adherence data versus pill counts. Ann Pharmacother 1993 27 (7 8) 851-855 (Pubitemid 23225667)
41. Mason B J., Matsuyama J R., Jue S G. Assessment of Sulfonylurea Adherence and Metabolic Control. Diabetes Educ 1995 21 (1) 52-57
42. Paes A H., Bakker A, Soe-Agnie C J. Measurement of patient compliance. Pharma World Sci 1998 20 (2) 73-77 (Pubitemid 28228437)
43. Brown J B., Nichols G A., Glauber H S. et al. Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus. Clin Ther 1999 21 (6) 1045-1057 (Pubitemid 29326162)
44. Khattab M S., Aboifotouh M A., Khan M Y. et al. Compliance and control of diabetes in a family practice setting, Saudi Arabia. East Mediterr Health J 1999 5 755-765
45. Sclar D A., Robison L M., Skaer T L. et al. Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race. Diabetes Educ 1999 25 (4) 531-532
46. Venturini F, Nichol M B., Sung J C. et al. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother 1999 33 (3) 281-288 (Pubitemid 29157736)
47. Ciechanowski P S., Katon W J., Russo J E. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000 160 (21) 3278-3285
48. Boccuzzi S J., Wogen J, Fox J et al. Utilization of oral hypoglycemic agents in a drug-insured U. S. population. Diabetes Care 2001 24 (8) 1411-1415 (Pubitemid 33716429)
49. Catalan V S., Couture J A., LeLorier J. Predictors of persistence of use of the novel antidiabetic agent acarbose. Arch Intern Med 2001 161 1106-1112 (Pubitemid 32685537)
50. Dailey G, Kim M S., Lian J F. Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus. Clin Ther 2001 23 (8) 1311-1320 (Pubitemid 32804123)
51. Dailey G, Kim M S., Lian J F. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res 2002 30 (1) 71-79 (Pubitemid 34618725)
52. Dezii C M., Kawabata H, Tran M. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J 2002 95 (1) 68-71 (Pubitemid 34131538)
53. Donnan P T., MacDonald T M., Morris A D. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med 2002 19 (4) 279-284 (Pubitemid 34592152)
54. Evans J M., Donnan P T., Morris A D. Adherence to oral hypoglycaemic agents prior to insulin therapy in type 2 diabetes. Diabet Med 2002 19 (8) 685-688 (Pubitemid 34985171)
55. Melikian C, White T J., Vanderplas A et al. Adherence to oral antidiabetic therapy in a managed care organiziation: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther 2002 24 (3) 460-467 (Pubitemid 34275867)
56. Morningstar B A., Sketris I S., Kephart G C. et al. Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada. J Clin Pharm Ther 2002 27 (3) 213-220 (Pubitemid 34748147)
57. Schectman J M., Nadkarni M M., Voss J D. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002 25 (6) 1015-1021 (Pubitemid 41110487)
58. Winkler A, Teuscher A U., Mueller B et al. Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly 2002 132 (27 28) 379-385 (Pubitemid 35285222)
59. Grant R W., Devita N G., Singer D E. et al. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003 26 (5) 1408-1412 (Pubitemid 36929171)
60. Guillausseau P J. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab 2003 29 (1) 79-81 (Pubitemid 36362620)
61. Hernández-Ronquillo L, Téllez-Zenteno J F., Garduño-Espinosa J et al. Factors associated with therapy noncompliance in type-2 diabetes patients. Salud Publica Mex 2003 45 (3) 191-197 (Pubitemid 36858701)
62. Kuo Y F., Raji M A., Markides K S. et al. Inconsistent use of diabetes medications, diabetes complications, and mortality in older mexican americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care 2003 26 (11) 3054-3060 (Pubitemid 37339498)
63. Rajagopalan R, Joyce A, Ollendorf D et al. Medication compliance in type 2 diabetes patients: retrospective data analysis. Value Health 2003 6 328
64. Rosen M I., Beauvais J E., Rigsby M O. et al. Neuropsychological correlates of suboptimal adherence to metformin. J Behav Med 2003 26 (4) 349-360 (Pubitemid 36890201)
65. Spoelstra J A., Stolk R P., Heerdink E R. et al. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy. Pharmacoepidemiol Drug Saf 2003 12 (2) 121-127 (Pubitemid 36304762)
66. Balkrishnan R, Rajagopalan R, Shenolikar R A. et al. Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis. Curr Med Res Opin 2004 20 (10) 1633-1640 (Pubitemid 39457551)
67. Hepke K L., Martus M T., Share D A. Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care 2004 10 144-151 (Pubitemid 38332389)
68. Kogut S J., Andrade S E., Willey C et al. Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation). Pharmacoepidemiol Drug Saf 2004 13 (9) 591-598 (Pubitemid 39264221)
69. Krapek K, King K, Warren S S. et al. Medication Adherence and Associated Hemoglobin A 1c in Type 2 Diabetes. Ann Pharmacother 2004 38 (9) 1357-1362 (Pubitemid 39100184)
70. Vanderpoel D R., Hussein M A., Watson-Heidari T et al. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Clin Ther 2004 26 (12) 2066-2075 (Pubitemid 40353616)
71. White T J., Vanderplas A, Chang E et al. The cost of nonadherence to oral antihyperglycemic medication in individuals with diabetes mellitus and concomitant diabetes mellitus and cardiovascular disease in a managed care enviroment. Dis Manage Health Outcomes 2004 12 (3) 181-188 (Pubitemid 38845095)
72. Charpentier G, Fleury F, Dubroca I et al. Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes Metab 2005 31 (2) 189-195 (Pubitemid 40577203)
73. Doró P, Benko R, Kosik E et al. Utilization of oral antihyperglycemic drugs over a 7-year period (1998 2004) in a Hungarian population and adherence to drug therapy. Eur J Clin Pharmacol 2005 61 (12) 893-897 (Pubitemid 41803699)
74. Hertz R P., Unger A N., Lustik M B. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther 2005 27 (7) 1064-1073 (Pubitemid 41262464)
75. Kardas P. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes Obes Metab 2005 7 (6) 722-728 (Pubitemid 41601077)
76. Rhee M K., Slocum W, Ziemer D C. et al. Patient adherence improves glycemic control. Diabetes Educ 2005 31 (29) 240-250 (Pubitemid 40529013)
77. Kalsekar I D., Madhavan S S., Amonkar M M. et al. Depression in patients with type 2 dibetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother 2006 40 (4) 605-611
78. Lawrence D B., Ragucci K R., Long L B. et al. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A 1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm 2006 12 (6) 466-471 (Pubitemid 47400587)
79. Mateo J F., Gil-Guillén V F., Mateo E et al. Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes. Int J Clin Pract 2006 60 (4) 422-428
80. Nau D P., Steinke D T., Williams L K. et al. Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother 2007 41 (11) 1792-1797 (Pubitemid 350044340)
81. Barron J, Wahl P, Fisher M et al. Effedt of Prescription Copayments on Adherence and Treatment Failure with Oral Antidiabetic Medications. P&T 2008 33 (9) 532-553
82. Briesacher B A., Andrade S E., Fouayzi H et al. Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions. Pharmacotherapy 2008 28 (49) 437-443 (Pubitemid 351466455)
83. Cheong C, Barner J C., Lawson K A. et al. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipientsrecipients. Clin Ther 2008 30 (10) 1893-1907
84. Karve S, Cleves M A., Helm M et al. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008 46 (11) 1125-1133
85. Pan F, Chernew M E., Fendrick A M. Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications. J Gen Intern Med 2008 23 (5) 611-614
86. Rozenfeld Y, Hunt J S., Plauschinat C et al. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care 2008 14 (2) 71-75 (Pubitemid 351312089)
87. Schmittdiel J A., Uratsu C S., Karter A J. et al. Why dont diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008 23 (5) 588-594
88. Briesacher B A., Andrade S E., Fouayzi H et al. Medication Adherence and the Use of Generic Drug Therapies. Am J Manag Care 2009 15 (7) 450-456
89. Choudhry N K., Shrank W H., Levin R L. et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009 15 (7) 457-464
90. Haupt D, Weitoft G R., Nilsson J L. Refill adherence to oral antihyperglycaemic drugs in Sweden. Acta Diabetol 2009 46 (3) 203-208
91. Karve S, Cleves M A., Helm M et al. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009 25 (9) 2303-2310
92. Prado-Aguilar C A., Martínez Y V., Segovia-Bernal Y et al. Performance of two questionnaires to measure treatment adherence in patients with Type-2 diabetes. BMC Public Health 2009 9 38
93. Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother 2009 43 (5) 950-957
94. Trinacty C M., Adams A S., Soumerai S B. et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res 2009 9 24
95. Vink N M., Klungel O H., Stolk R P. et al. Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiol Drug Saf 2009 18 (2) 159-165
96. Norris S L., Engelgau M M., Narayan K M. Effectiveness of Self-Management Training in Type 2 Diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001 24 (3) 561-587 (Pubitemid 32198430)
97. Vermeire E IJJ, Wens J, Van Royen P et al. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005 2 CD003638
98. Lewis D. Computer-based Approaches to Patient Education: A Review of the Literature. JAMA 1999 6 (4) 272-282 (Pubitemid 29328566)
99. Higgings N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication. Age Ageing 2004 33 (3) 224-229 (Pubitemid 38635037)
100. McDonald H P., Garg A X., Haynes R B. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002 288 (22) 2868-2879 (Pubitemid 35425073)